4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-019621
Chief Financial Officer sold 10,000 shares at an average $40.24 ($402,425)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-09 | Exercise or conversion : show line 1 in the form | +10,000 | $6.32 | $63,200 | 31,064 | D |
| 2021-03-09 | Sale : show line 2 in the form | −7,110 | $40.02 | $284,542 | 23,954 | D |
| 2021-03-09 | Sale : show line 3 in the form | −2,890 | $40.79 | $117,883 | 21,064 | D |
| Open-market sales · 10,000 sh · avg $40.24 · $402,425 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-09 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −10,000 | 55,000 | D |
Loading xslF345X03/doc4.xml…